Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

LUCD

Lucid Diagnostics Inc

Apr 19 • 04:00PM ET

0.7965

Dollar change -0.0025
Percentage change -0.31	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.26	Insider Own	70.38%	Shs Outstand	42.33M	Perf Week	-1.55%
Market Cap	38.42M	Forward P/E	-	EPS next Y	-0.71	Insider Trans	0.00%	Shs Float	14.29M	Perf Month	-28.24%
Income	-52.67M	PEG	-	EPS next Q	-0.23	Inst Own	3.66%	Short Float	3.09%	Perf Quarter	-45.07%
Sales	2.43M	P/S	15.81	EPS this Y	84.98%	Inst Trans	-5.10%	Short Ratio	2.76	Perf Half Y	-34.71%
Book/sh	-0.49	P/B	-	EPS next Y	18.66%	ROA	-176.20%	Short Interest	0.44M	Perf Year	-50.22%
Cash/sh	0.39	P/C	2.03	EPS next 5Y	-	ROE	-507.97%	52W Range	0.76 - 1.85	Perf YTD	-43.51%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-110.66%	ROI	-	52W High	-56.95%	Beta	1.54
Dividend TTM	-	Quick Ratio	0.75	Sales past 5Y	103.89%	Gross Margin	-249.14%	52W Low	4.30%	ATR (14)	0.07
Dividend Ex-Date	-	Current Ratio	0.75	EPS Y/Y TTM	18.58%	Oper. Margin	-1996.79%	RSI (14)	26.03	Volatility	6.06% 7.94%
Employees	70	Debt/Eq	-	Sales Y/Y TTM	544.03%	Profit Margin	-2169.11%	Recom	1.00	Target Price	3.83
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	36.02%	Payout	-	Rel Volume	0.74	Prev Close	0.80
Sales Surprise	0.87%	EPS Surprise	-478.26%	Sales Q/Q	828.57%	Earnings	Mar 26 AMC	Avg Volume	159.76K	Price	0.80
SMA20	-12.74%	SMA50	-28.35%	SMA200	-39.75%	Trades		Volume	118,111	Change	-0.31%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-27-21	Initiated	Ascendiant Capital Markets	Buy	$16
Nov-08-21	Initiated	Needham	Buy	$17
Nov-08-21	Initiated	Cantor Fitzgerald	Overweight	$21
Nov-08-21	Initiated	BTIG Research	Buy	$14

Apr-08-24 08:30AM	Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-28-24 09:47AM	PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript (Insider Monkey) -18.19%
02:00AM	Q4 2023 PAVmed Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-27-24 12:35PM	Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:14AM	Q4 2023 Lucid Diagnostics Inc Earnings Call (Thomson Reuters StreetEvents)
07:32PM	Loading…
Mar-26-24 07:32PM	PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results (PR Newswire) -6.60%
Mar-25-24 10:53PM	LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:30PM	Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Mar-21-24 09:30AM	Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard Esophageal Precancer Testing in a Screening Population (PR Newswire)
Mar-20-24 08:30AM	Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference (PR Newswire)
Mar-12-24 08:30AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024 (PR Newswire)
Feb-16-24 05:00PM	Lucid Diagnostics Provides Update Regarding World Trade Center Health Program (PR Newswire)
Feb-15-24 07:45AM	Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck Esophageal Cell Collection Device during Congressional Testimony (PR Newswire)
Feb-08-24 07:45AM	Lucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors (PR Newswire)
Dec-17-23 03:00PM	The 3 Most Undervalued Penny Stocks to Buy in December (InvestorPlace)
08:30AM	Loading…
Dec-12-23 08:30AM	Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies (PR Newswire)
Dec-11-23 09:00AM	PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders (PR Newswire)
Dec-04-23 04:20PM	PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split (PR Newswire)
Nov-20-23 12:44PM	PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-16-23 09:07AM	Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript (Insider Monkey)
09:00AM	Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts (PR Newswire)
Nov-14-23 05:43PM	PAVmed Provides Business Update and Third Quarter Financial Results (PR Newswire) +12.07%
Nov-13-23 05:40PM	Lucid Diagnostics Provides Business Update and Third Quarter Financial Results (PR Newswire)
Nov-09-23 09:00AM	Lucid Diagnostics Launches Next-Generation EsoGuard Esophageal DNA Test and Announces Upcoming Investor Day (PR Newswire)
Nov-02-23 09:18AM	Lucid Diagnostics to Present at Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services Forum (PR Newswire)
Nov-01-23 09:10AM	PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2023 (PR Newswire)
Oct-31-23 09:00AM	Lucid Diagnostics Announces PREVENT and PREVENT-FF Registries of EsoGuard Esophageal Precancer Detection (PR Newswire)
08:55AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2023 (PR Newswire)
Sep-21-23 08:30AM	PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
Sep-07-23 09:20AM	Lucid Diagnostics Releases Positive Data from First Prospective Clinical Utility Study of EsoGuard® Esophageal Precancer Detection (PR Newswire)
09:00AM	Loading…
Sep-06-23 09:00AM	Lucid Diagnostics Releases Positive Data Demonstrating Clinical Utility of EsoGuard® Esophageal Precancer Detection in Fire Fighters (PR Newswire) +5.88%
Aug-24-23 09:00AM	Lucid Diagnostics Executes First Direct Employer Contract to Provide EsoGuard® Esophageal Precancer Testing as an Employee Benefit (PR Newswire)
Aug-16-23 12:25AM	Q2 2023 Lucid Diagnostics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-15-23 08:17PM	PAVmed Provides Business Update and Second Quarter Financial Results (PR Newswire)
Aug-14-23 06:48PM	Lucid Diagnostics Provides Business Update and Second Quarter Financial Results (PR Newswire)
Jul-31-23 06:19PM	PAVmed to Hold a Business Update Conference Call and Webcast on August 16, 2023 (PR Newswire)
06:00PM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 15, 2023 (PR Newswire)
Jul-26-23 08:30AM	Lucid Diagnostics to Present at the Canaccord Genuity 43rd Annual Growth Conference (PR Newswire)
Jul-19-23 09:04AM	PAVmed and Lucid Chairman and Chief Executive Officer, Dr. Lishan Aklog, Testifies at U.S. House of Representatives Energy and Commerce Committee, Hearing on Life-Saving Innovations and Medicare Coverage (PR Newswire)
Jun-28-23 04:05PM	PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire)
Jun-14-23 04:05PM	PAVmed to Participate in Healthcare Virtual Conference Presented by Maxim Group LLC (PR Newswire)
Jun-05-23 07:00AM	Lucid Diagnostics Launches First EsoGuard® Mobile Test Unit (PR Newswire)
Jun-02-23 07:00AM	PAVmed Digital Health Subsidiary, Veris Health, Joins Cancer Moonshot's CancerX Partnership as Founding Member (PR Newswire)
May-18-23 12:03PM	PAVmed Inc. (NASDAQ:PAVM) Q1 2023 Earnings Call Transcript (Insider Monkey)
12:12AM	Q1 2023 PAVmed Inc Earnings Call (Thomson Reuters StreetEvents)
May-17-23 06:05AM	Lucid Diagnostics First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
May-16-23 05:00PM	PAVmed Provides Business Update and First Quarter Financial Results (PR Newswire)
May-15-23 06:21PM	Lucid Diagnostics Provides Business Update and First Quarter Financial Results (PR Newswire)
May-11-23 08:45AM	Lucid Diagnostics and Collaborators Present New EsoGuard® and EsoCheck® Data at Digestive Disease Week® (DDW) 2023 Conference (PR Newswire)
May-05-23 09:00AM	PAVmed to Hold a Business Update Conference Call and Webcast on May 17, 2023 (PR Newswire)
09:00AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 16, 2023 (PR Newswire)
Apr-26-23 06:08AM	Are Investors Undervaluing Lucid Diagnostics Inc. (NASDAQ:LUCD) By 43%? (Simply Wall St.)
Apr-25-23 08:45AM	PAVmed Digital Health Subsidiary, Veris Health, Appoints Gary Manning as President (PR Newswire)
Apr-19-23 08:45AM	PAVmed Digital Health Subsidiary, Veris Health, to Present Comprehensive Meta-analysis on Impact of Remote Patient Monitoring in Oncology at HIMSS (PR Newswire) +8.84%
Apr-18-23 08:45AM	Lucid Diagnostics Reports Publication of Future Effective Foundational Local Coverage Determination by Medicare Administrative Contractor Noridian Healthcare Solutions (PR Newswire) +8.09%
Apr-17-23 09:45PM	Lucid Diagnostics to Present at 22nd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-31-23 12:45PM	Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and Cancer (PR Newswire)
Mar-20-23 09:03PM	PAVmed Inc. (NASDAQ:PAVM) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-17-23 04:15AM	Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-16-23 01:22AM	Q4 2022 PAVmed Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-15-23 02:43AM	Q4 2022 Lucid Diagnostics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-23 07:09PM	PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results (PR Newswire) +6.83%
01:28PM	/C O R R E C T I O N -- Lucid Diagnostics/ (PR Newswire)
Mar-03-23 08:15AM	PAVmed to Hold a Business Update Conference Call and Webcast on March 15, 2023 (PR Newswire)
08:15AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 14, 2023 (PR Newswire)
Feb-28-23 08:30AM	PAVmed Digital Health Subsidiary Veris Health's Veris Cancer Care Platform Goes Live (PR Newswire)
Feb-15-23 08:30AM	Lucid Diagnostics Holds First #CheckYourFoodTube Precancer Testing Event (PR Newswire)
Jan-18-23 06:24AM	PAVmed, Lucid Diagnostics Pause Some Development Programs, Announce Layoffs (Benzinga) -13.46%
Jan-17-23 04:05PM	PAVmed and Lucid Diagnostics Provide Strategic Business Update (Business Wire) +20.00%
Jan-11-23 08:00AM	PAVmed and Lucid Diagnostics to Provide Strategic Business Update (Business Wire)
Dec-22-22 08:25AM	PAVmed Partners with Novosound on Ultrasound Imaging Technology (Business Wire)
Dec-15-22 08:25AM	PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform (Business Wire)
Dec-12-22 08:43AM	Here's Why Lucid Diagnostics (NASDAQ:LUCD) Must Use Its Cash Wisely (Simply Wall St.) -5.82%
Dec-08-22 08:25AM	Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry (Business Wire) +5.52%
Dec-01-22 08:25AM	Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research (Business Wire)
Nov-15-22 04:20PM	PAVmed Provides Business Update and Third Quarter 2022 Financial Results (Business Wire) -11.89%
Nov-14-22 04:40PM	Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results (Business Wire)
Nov-10-22 08:25AM	Lucid Diagnostics to Participate in Canaccord Genuitys MedTech, Diagnostics and Digital Health & Services Forum (Business Wire)
Nov-09-22 08:25AM	Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer (Business Wire) +15.14%
Nov-02-22 08:25AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022 (Business Wire)
Aug-15-22 04:25PM	Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results (Business Wire)
09:31AM	What Type Of Shareholders Make Up Lucid Diagnostics Inc.'s (NASDAQ:LUCD) Share Registry? (Simply Wall St.)
Aug-11-22 08:25AM	Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio (Business Wire)
Aug-04-22 08:25AM	Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics EsoGuard® and EsoCheck® Technologies (Business Wire) +5.67%
Aug-02-22 08:25AM	Lucid Diagnostics Laboratory Executes Four New Participating Provider Agreements (Business Wire)
Aug-01-22 08:25AM	Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022 (Business Wire)
Jul-18-22 08:25AM	Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference (Business Wire)
Jul-04-22 01:57PM	Is Lucid Diagnostics (NASDAQ:LUCD) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
May-13-22 08:25AM	PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO (Business Wire)
May-11-22 04:00PM	Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results (Business Wire) -7.46%
May-09-22 08:25AM	Lucid Diagnostics Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans (Business Wire) -6.70%
Apr-25-22 08:25AM	Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022 (Business Wire)
Apr-14-22 12:02PM	2 Strong Buy Penny Stocks That Offer Massive Potential Gains (TipRanks)
Apr-04-22 08:25AM	Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination (Business Wire)
Mar-30-22 08:25AM	Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference (Business Wire)
Mar-29-22 04:11PM	PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results (Business Wire) +6.56%
11:35AM	Lucid Diagnostics to Have a Productive Year, Says Cantor Fitzgerald (Investing.com)
Mar-28-22 04:47PM	Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results (Business Wire)
Mar-24-22 08:25AM	PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study (Business Wire) +5.94%
Mar-23-22 08:25AM	PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers (Business Wire)

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lapidus Stanley	Director	Sep 26 '23	Sale	1.45	29,747	43,173	101,592	Sep 27 08:53 PM
Lapidus Stanley	Director	Sep 25 '23	Sale	1.43	200	286	131,339	Sep 27 08:53 PM
Lapidus Stanley	Director	Sep 21 '23	Sale	1.44	100	144	131,539	Sep 22 06:39 PM
Lapidus Stanley	Director	Sep 20 '23	Sale	1.45	3,817	5,531	131,639	Sep 22 06:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LUCD

Lucid Diagnostics Inc

Upgrade your FINVIZ experience